Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study
Open Access
- 1 May 2013
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 219
Abstract
Toll-like receptors (TLRs) and the transcription factor nuclear factor-κB (NFκB) are important in inflammation and cancer.Keywords
This publication has 64 references indexed in Scilit:
- Inflammation meets cancer, with NF-κB as the matchmakerNature Immunology, 2011
- Prognostic significance of MMP‐9 and TIMP‐1 serum and tissue expression in breast cancerInternational Journal of Cancer, 2008
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progressionBreast Cancer Research and Treatment, 2006
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancerBreast Cancer Research and Treatment, 2005
- Multiple Testing. Part I. Single-Step Procedures for Control of General Type I Error RatesStatistical Applications in Genetics and Molecular Biology, 2004
- Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast CancerJAMA, 2003
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activationProceedings of the National Academy of Sciences of the United States of America, 1997